OAM
PTLA

Oppenheimer Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Oppenheimer Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-26,200
Closed -$186K – 1524
2020
Q1 		$186K Sell
26,200
-3,996
-13% -$49.9K ﹤0.01% 984
2019
Q4 		$721K Sell
30,196
-3,287
-10% -$90.7K 0.02% 712
2019
Q3 		$898K Buy
33,483
+3,790
+13% +$106K 0.02% 644
2019
Q2 		$806K Sell
29,693
-2,941
-9% -$92.2K 0.02% 685
2019
Q1 		$1.13M Buy
32,634
+24,553
+304% +$708K 0.03% 575
2018
Q4 		$158K Sell
8,081
-574
-7% -$11.8K ﹤0.01% 1073
2018
Q3 		$231K Buy
8,655
+2,576
+42% +$84.1K 0.01% 1043
2018
Q2 		$230K Buy
+6,079
New +$233K 0.01% 1033
2017
Q4 		– Sell
-2,862
Closed -$155K – 1582
2017
Q3 		$155K Buy
2,862
+2,047
+251% +$120K ﹤0.01% 1102
2017
Q2 		$46K Sell
815
-240
-23% -$9.61K ﹤0.01% 1366
2017
Q1 		$41K Buy
+1,055
New +$33.6K ﹤0.01% 1389

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Oppenheimer Asset Management's PTLA Position: Q2 2020 in Review

Oppenheimer Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 26,200 shares — an estimated $186K sold.

Oppenheimer Asset Management first reported a position in PTLA in Q1 2017 and held it in 11 quarters. The position peaked at $1.13M in Q1 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Oppenheimer Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Oppenheimer Asset Management sold 26,200 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $186K.
  • Oppenheimer Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2017 and held it in 11 quarters.
  • Oppenheimer Asset Management's Portola Pharmaceuticals, Inc. position peaked at $1.13M in Q1 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.